Evidence map›Paper›PMID 29574773›Full record

ArticleJournal of cellular physiology2018

Omega-3 fatty acids modulate the lipid profile, membrane architecture, and gene expression of leiomyoma cells.

Md Soriful Islam, Clara Castellucci, Rosamaria Fiorini, Stefania Greco, Riccardo Gagliardi, Alessandro Zannotti, Stefano R Giannubilo, Andrea Ciavattini, Natale G Frega, Deborah Pacetti and 1 more

Abstract read
In one paragraph

Article in Journal of cellular physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Uterine Fibroids and Diet.International journal of environmental research and public health · 2021
    Review
  12. Simvastatin ameliorates altered mechanotransduction in uterine leiomyoma cells.American journal of obstetrics and gynecology · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Md Soriful IslamDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy.
Clara CastellucciDepartment of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
Rosamaria FioriniDepartment of Life and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy.
Stefania GrecoDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy.
Riccardo GagliardiEureka srl - Lab Division, R&D Department, Chiaravalle (AN), Italy.
Alessandro ZannottiDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy.
Stefano R GiannubiloDepartment of Clinical Science, Università Politecnica delle Marche, Ancona, Italy.
Andrea CiavattiniDepartment of Clinical Science, Università Politecnica delle Marche, Ancona, Italy.
Natale G FregaDepartment of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy.
Deborah PacettiDepartment of Agricultural, Food and Environmental Sciences, Università Politecnica delle Marche, Ancona, Italy.
Pasquapina CiarmelaDepartment of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy.ORCID http://orcid.org/0000-0002-4400-3786
Marche Polytechnic University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uterine leiomyomas (fibroids or myomas) are the most common benign tumors of premenopausal women and new medical treatments are needed. This study aimed to determine the effects of omega-3 fatty acids on the lipid profile, membrane architecture and gene expression patterns of extracellular matrix components (collagen1A1, fibronectin, versican, or activin A), mechanical signaling (integrin β1, FAK, and AKAP13), sterol regulatory molecules (ABCG1, ABCA1, CAV1, and SREBF2), and mitochondrial enzyme (CYP11A1) in myometrial and leiomyoma cells. Myometrial tissues had a higher amount of arachidonic acid than leiomyoma tissues while leiomyoma tissues had a higher level of linoleic acid than myometrial tissues. Treatment of primary myometrial and leiomyoma cells with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) reduced the monounsaturated fatty acid (MUFA) content and increased the polyunsaturated fatty acid (PUFA) content in both cell types. Myometrial and leiomyoma cell membranes were in the liquid-crystalline phase, but EPA- and DHA-treated cells had decreased membrane fluidity. While we found no changes in the mRNA expression of ECM components, EPA and DHA treatment reduced levels of ABCG1, ABCA1, and AKAP13 in both cell types. EPA and DHA also reduced FAK and CYP11A1 expression in myometrial cells. The ability of omega-3 fatty acids to remodel membrane architecture and downregulate the expression of genes involved in mechanical signaling and lipid accumulation in leiomyoma cells offers to further investigate this compound as preventive and/or therapeutic option.

Indexed as

Gene Expression Regulation, NeoplasticActivinsAdultCell MembraneCholesterol Side-Chain Cleavage EnzymeDocosahexaenoic AcidsEicosapentaenoic AcidExtracellular MatrixFatty Acids, Omega-3FemaleHumansLeiomyomaLipidsMiddle AgedMyometriumRNA, Messengeractivin AActivinsCholesterol Side-Chain Cleavage EnzymeDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, Omega-3LipidsRNA, MessengerSterolsABCG1 and ABCA1lipid profilemechanical signalingomega-3 fatty acidsuterine leiomyoma

Identifiers

PMID29574773
PMCPMC13482449
OpenAlexW2791362887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.